Ardan M Saguner

Ardan M Saguner is an expert in Cardiology at University Hospital of Zurich (Switzerland). As of October 2026, ScienceLeadR ranks Ardan M Saguner in the top 1% of experts worldwide for Cardiomyopathies, Cardiovascular Abnormalities and Congenital Abnormalities. Ardan M Saguner has authored 394 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 3 of them ongoing. SLR score: 1,235 (community average: 125). How the SLR is computed.

Cardiology

Subspecialties: Public Health - Genetics - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 28, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2010 - 2026

Source: PubMed

University Hospital of Zurich

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 394

Citations

Citations: 6 474 1st author: 28 Last author: 78 Unique author: 1

Main journals

Europace 67

Eur Heart J 41

Heart Rhythm 35

Praxis (Bern 1994) 25

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year	Citations
Association of exercise with phenotype and arrhythmic outcomes in gene-elusive arrhythmogenic cardiomyopathy. PMID 42933878 — exercise, genes, cardiovascular diseases, phenotype, cardiomyopathies	Open Heart	2026	0
Tricuspid regurgitation and outcomes in arrhythmogenic right ventricular cardiomyopathy: role of tricuspid annulus dilatation. PMID 42669127 — cardiology, arrhythmogenic right ventricular dysplasia, tricuspid valve insufficiency, cardiomyopathies	Eur Heart J Top journal	2026	1
Pulmonary Vein Isolation Using Pulsed Field Ablation With vs Without Posterior Wall Isolation in Patients With Symptomatic Persistent Atrial Fibrillation: The PIFPAF-PFA Randomized Clinical Trial. PMID 42667231 — pulmonary veins, safety, arrhythmias, cardiac, atrial fibrillation, veins, pulsed field ablation	JAMA Top journal	2026	6
Desmoplakin Mutations in Cardiac Fibroblasts Cause TGFβ1-Mediated Pathological Fibrogenesis in Desmoplakin Cardiomyopathy Via Beclin-1 Regulation. PMID 42615127 — cells, genes, autophagy, fibrosis, heart, desmoplakins, cardiovascular system, phenotype, collagen, beclin-1, fibroblasts, mutation, cardiomyopathies, endocytosis	Circ Res	2026	0
Updating national diagnostic reference levels for adult cardiac interventional procedures in Switzerland. PMID 42378754 — biophysics, diagnostic reference levels, air	Phys Med	2026	0

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4

Phase 1 1

Phase 4 1

By status:

Completed 3

Recruiting 2

Active not recruiting 1

By type:

Interventional 4

Observational 2

By Monocentric/Multicentric:

monocentric 3

multicentric2to4 1

multicentric5to9 1

multicentricup10 1

Main Topics

Cardiovascular Diseases 5

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
The PIFPAF PFA Study NCT05986526 — pulmonary veins, arrhythmias, cardiac, multiple chronic conditions, atrial fibrillation, veins, pulsed field ablation	N/A	Active not recruiting	2023
Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia a Single Center Phase II Clinical Trial NCT05594368 — radiotherapy, tachycardia, ventricular, arrhythmias, cardiac, multiple chronic conditions, tachycardia, therapeutics, catheter ablation, catheters	Phase 1	Recruiting	2022
International Ledless Pacemaker Registry NCT05528029 — registries, femoral vein, heart, fluoroscopy, atrial fibrillation, veins	N/A	Recruiting	2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice